XtalPi (HKG:2228) looks to raise about HK$2.65 billion via the sale of shares, according to a Hong Kong bourse filing Friday.
The pharma research firm is looking to sell over 285.9 million shares at HK$9.28 each to raise funds for the research and development of its product pipeline.
The shares represent 7.12% of the company's issued share capital, and 6.64% on an enlarged basis.
CLSA, Guotai Junan Securities (Hong Kong), Jefferies Hong Kong, Deutsche Bank, and CMB International Capital were appointed placing agents for the offering.
Shares gained over 3% in midday trade Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.